Muscarinic antagonist control of myopia: A molecular search for the M1 receptor in chick

Molecular Vision

Volumn 10, Issue , 2004, Pages 787-793

  Yin, George C ^a   Gentle, Alex ^a   McBrien, Neville A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; COMPLEMENTARY DNA; PIRENZEPINE; PRIMER DNA;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CHICKEN; CONTROLLED STUDY; DNA TEMPLATE; DRUG MECHANISM; EYE; GENE EXPRESSION; MEDICAL RESEARCH; MYOPIA; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RAT; RETINA; RNA ANALYSIS; SOUTHERN BLOTTING; VALIDATION PROCESS; ANIMAL; BRAIN; DNA PROBE; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; UVEA;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BRAIN; CHICKENS; DNA PRIMERS; DNA PROBES; DNA, COMPLEMENTARY; GENE EXPRESSION; MUSCARINIC ANTAGONISTS; MYOPIA; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M1; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UVEA;

EID: 16644396456     PISSN: 10900535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bedrossian RH. The effect of atropine on myopia. Ophthalmology 1979; 86:713-9.
2. Stone RA, Lin T, Laties AM. Muscarinic antagonist effects on experimental chick myopia. Exp Eye Res 1991; 52:755-8.
3. McBrien NA, Moghaddam HO, Reeder AP. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci 1993; 34:205-15.
4. Jones SVP, Levey AI, Weiner DM, Ellis J, Novotny E, Yu SH, Dorje F, Wess J, Brann MR. Muscarinic acetylcholine receptors. In: Brann MR, editor. Molecular biology of G-protein-coupled receptors. Boston: Birkhäuser; 1992. p. 170-97.
5. Brann MR, Ellis J, Jorgensen H, Hill-Eubanks D, Jones SV. Muscarinic acetylcholine receptor subtypes: localization and structure/function. Prog Brain Res 1993; 98:121-7.
6. D'Imperio N, Giuliani Piccari G, Lepore AM, Sarti F, Dal Monte PR. Pirenzepine in the treatment of duodenal ulcer. Scand J Gastroenterol Suppl 1979; 57:41-4.
7. Stockbrugger R, Jaup B, Hammer R, Dotevall G. Inhibition of gastric acid secretion by pirenzepine (LS 519) in man. Scand J Gastroenterol 1979; 14:615-20.
8. Carmine AA, Brogden RN. Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases. Drugs 1985; 30:85-126.
9. Cottriall CL, McBrien NA. The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew. Invest Ophthalmol Vis Sci 1996; 37:1368-79.
10. Leech EM, Cottriall CL, McBrien NA. Pirenzepine prevents form deprivation myopia in a dose dependent manner. Ophthalmic Physiol Opt 1995; 15:351-6.
11. Tan DT, Lam D, Chua WH, Crockett RS, Asian Pirenzepine Study Group. Pirenzepine ophthalmic gel (PIR): Safety and efficacy for pediatric myopia in a one-year study in Asia. ARVO Annual Meeting; 2003 May 4-9; Fort Lauderdale, FL.
12. Siatkowski R, Cotter S, Miller J, Scher C, Crockett RS, Novack GD, Pirenzepine Study Group. Pirenzepine 2% ophthalmic gel retards myopic progression in 8-12 year old children. ARVO Annual Meeting; 2003 May 4-9; Fort Lauderdale, FL.
13. Cottriall CL, Truong HT, McBrien NA. Inhibition of myopia development in chicks using himbacine: a role for M4 receptors? Neuroreport 2001; 12:2453-6.
14. McBrien NA, Cottriall CL, Truong HT. Cholinergic control of ocular growth: a brief overview. In: Thorn F, Trolio D, Gwiazda J, editors. Proceedings of the VIII International Conference on Myopia; 2000 Jul 7-9; Boston: Myopia 2000 Inc.; 2000. p. 190-4.
15. Luft WA, Ming Y, Stell WK. Variable effects of previously untested muscarinic receptor antagonists on experimental myopia. Invest Ophthalmol Vis Sci 2003; 44:1330-8.
16. Fischer AJ, Miethke P, Morgan IG, Stell WK. Cholinergic amacrine cells are not required for the progression and atropine-mediated suppression of form-deprivation myopia. Brain Res 1998; 794:48-60.
17. Schwahn HN, Kaymak H, Schaeffel F. Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick. Vis Neurosci 2000; 17:165-76.
18. Tietje KM, Nathanson NM. Embryonic chick heart expresses multiple muscarinic acetylcholine receptor subtypes. Isolation and characterization of a gene encoding a novel m2 muscarinic acetylcholine receptor with high affinity for pirenzepine. J Biol Chem 1991; 266:17382-7.
19. Truong HT, Cottriall CL, McBrien NA. Expression of muscarinic receptors in tree shrew ocular tissues. Invest Ophthalmol Vis Sci 2000; 41:S132.
20. Tietje KM, Goldman PS, Nathanson NM. Cloning and functional analysis of a gene encoding a novel muscarinic acetylcholine receptor expressed in chick heart and brain. J Biol Chem 1990; 265:2828-34.
21. Gadbut AP, Galper JB. A novel M3 muscarinic acetylcholine receptor is expressed in chick atrium and ventricle. J Biol Chem 1994; 269:25823-9.
22. Creason S, Tietje KM, Nathanson NM. Isolation and functional characterization of the chick M5 muscarinic acetylcholine receptor gene. J Neurochem 2000; 74:882-5.
23. Lin LL, Shih YF, Tsai CB, Chen CJ, Lee LA, Hung PT, Hou PK. Epidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995. Optom Vis Sci 1999; 76:275-81.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
25. Gentle A, Liu Y, Martin JE, Conti GL, McBrien NA. Collagen gene expression and the altered accumulation of scleral collagen during the development of high myopia. J Biol Chem 2003; 278:16587-94.
26. Tata AM, Vilaro MT, Mengod G. Muscarinic receptor subtypes expression in rat and chick dorsal root ganglia. Brain Res Mol Brain Res 2000; 82:1-10.
27. Chomczynski P. One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal Biochem 1992; 201:134-9.
28. Ellis J, Seidenberg M. Site-directed mutagenesis implicates a threonine residue in TM6 in the subtype selectivities of UH-AH 37 and pirenzepine at muscarinic receptors. Pharmacology 2000; 61:62-9.
29. Caulfield MP. Muscarinic receptors-characterization, coupling and function. Pharmacol Ther 1993; 58:319-79.